Neuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome

Author(s): Emmanuel Navarro-Flores, Pilar Pérez-Ros, Francisco Miguel Martínez-Arnau, Iván Julían-Rochina, Omar Cauli*.

Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)

Volume 18 , Issue 8 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Diabetic Foot Syndrome (DFS) is a common long-term complication of diabetes mellitus. DFS has recently been associated with adverse effects on brain function which could further impair the quality of life of these patients, as well as increase the social and economic burden, morbidity, and premature mortality of the disease. The current knowledge of neuropsychiatric alterations e.g. cognitive impairment, gait disorder, depression, and quality of life in patients with diabetic foot syndrome is summarized. The cognitive domains altered in DFS are executive function, memory, and psychomotor speed. Compared to diabetic patients without DFS, individuals with DFS present gait alterations caused by changes in several spatio-temporal parameters and lower-limb kinematics. The increased rates of anxiety and depression among patients with DFS were related to several factors, including female sex, a smoking habit, age under 50 years, and foot ulceration exceeding 7 months' duration. The role of infections and the use of preventive antimicrobial treatment need further studies regarding their effect on comorbid neuropsychiatric disorders. The care of these patients should include the prevention, detection and treatment of these neuropsychiatric disorders in order to improve their quality of life.

Keywords: Cognitive dysfunction, gait disorders, postural balance, depression, daily living activities, infection.

[1]
Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep 2018; 18(6): 33.
[http://dx.doi.org/10.1007/s11892-018-1005-5] [PMID: 29671082]
[2]
Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366(9498): 1719-24.
[http://dx.doi.org/10.1016/S0140-6736(05)67698-2] [PMID: 16291066]
[3]
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-81.
[http://dx.doi.org/10.1016/j.diabres.2018.02.023] [PMID: 29496507]
[4]
Bohn B, Grünerbel A, Altmeier M, et al. Diabetic foot syndrome in patients with diabetes. A multicenter German/Austrian DPV analysis on 33 870 patients. Diabetes Metab Res Rev 2018; 34(6)e3020
[http://dx.doi.org/10.1002/dmrr.3020] [PMID: 29726089]
[5]
Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K. International Working Group on the Diabetic Foot (IWGDF). Prevention and management of foot problems in diabetes: A Summary Guidance for Daily Practice 2015, based on the IWGDF guidance documents. Diabetes Res Clin Pract 2017; 124: 84-92.
[http://dx.doi.org/10.1016/j.diabres.2016.12.007] [PMID: 28119194]
[6]
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis. Ann Med 2017; 49(2): 106-16.
[http://dx.doi.org/10.1080/07853890.2016.1231932] [PMID: 27585063]
[7]
Carro GV, Saurral R, Sagüez FS, Witman EL. Diabetic foot among hospitalized patients in Latin America. Medicina (B Aires) 2018; 78(4): 243-51.
[PMID: 30125251]
[8]
Mesa-Pérez JA, Vitarella G, Rosas-Guzmán J, et al. Guías ALAD de pie diabético. Rev ALAD 2010; 18: 73-86.
[9]
Aumiller WD, Dollahite HA. Pathogenesis and management of diabetic foot ulcers. JAAPA 2015; 28(5): 28-34.
[http://dx.doi.org/10.1097/01.JAA.0000464276.44117.b1] [PMID: 25853673]
[10]
Arshad N, Lin TS, Yahaya MF. Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism. CNS Neurol Disord Drug Targets 2018; 17(8): 595-603.
[http://dx.doi.org/10.2174/1871527317666180724143258] [PMID: 30047340]
[11]
Farzamfar B, Nazari R, Bayanolhagh S. Diabetic Foot Ulcer. Gangrene Manag - New Adv Curr Trends 2013.
[http://dx.doi.org/10.5772/55588]
[12]
Paraskevas KI, Baker DM, Pompella A, Mikhailidis DP. Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview. Ann Vasc Surg 2008; 22(3): 481-91.
[http://dx.doi.org/10.1016/j.avsg.2007.12.012] [PMID: 18411027]
[13]
Bayram EH, Sezer AD, Elçioğlu HK. Diabetic neuropathy and treatment strategy - new challenges and applications. Smart Drug Deliv Syst 2016.
[14]
Clayton W, Elasy TA. A Review of the pathophysiology, classification, and treatment of foot ulcers in diabetic patients. Clin Diabetes 2009; 27(2): 52-8.
[http://dx.doi.org/10.2337/diaclin.27.2.52]
[15]
Ousey K, Chadwick P, Jawien A, et al. Identifying and treating foot ulcers in patients with diabetes: Saving feet, legs and lives. J Wound Care 2018; 27(Sup5): S1-S52.
[http://dx.doi.org/10.12968/jowc.2018.27.Sup5.S1] [PMID: 29738280]
[16]
Edsberg LE, Black JM, Goldberg M, McNichol L, Moore L, Sieggreen M. Revised national pressure ulcer advisory panel pressure injury staging system: Revised pressure injury staging system. J Wound Ostomy Continence Nurs 2016; 43(6): 585-97.
[http://dx.doi.org/10.1097/WON.0000000000000281] [PMID: 27749790]
[17]
Ousey K, McIntosh C. Topical antimicrobial agents for the treatment of chronic wounds Br J Community Nurs 2009; 14(9): S6, S8, S10 passim.
[http://dx.doi.org/10.12968/bjcn.2009.14.Sup4.43909]
[18]
Jens W, Ahmed A. Peripheral nervous system involvement in diabetes and role of rehabilitation Int J Neurorehabilitation 2016; 03- 06.
[http://dx.doi.org/10.4172/2376-0281.1000233]
[19]
Sima AAF, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490(1-3): 187-97.
[http://dx.doi.org/10.1016/j.ejphar.2004.02.056] [PMID: 15094085]
[20]
Pompili M, Fiorillo A. Editorial: Unmet needs in modern psychiatry. CNS Neurol Disord Drug Targets 2017; 16(8): 857.
[PMID: 29474168]
[21]
Alam U, Riley DR, Jugdey RS, et al. Diabetic neuropathy and gait: A review. Diabetes Ther 2017; 8(6): 1253-64.
[http://dx.doi.org/10.1007/s13300-017-0295-y] [PMID: 28864841]
[22]
Baydas G, Tuzcu M, Yasar A, Baydas B. Early changes in glial reactivity and lipid peroxidation in diabetic rat retina: Effects of melatonin. Acta Diabetol 2004; 41(3): 123-8.
[http://dx.doi.org/10.1007/s00592-004-0155-x] [PMID: 15666580]
[23]
Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000; 23(11): 542-9.
[http://dx.doi.org/10.1016/S0166-2236(00)01656-8] [PMID: 11074263]
[24]
Callisaya M, Nosaka K. Effects of exercise on type 2 diabetes mellitus-related cognitive impairment and dementia. J Alzheimers Dis 2017; 59(2): 503-13.
[http://dx.doi.org/10.3233/JAD-161154] [PMID: 28598841]
[25]
Li W, Huang E, Gao S. Type 1 diabetes mellitus and cognitive impairments: A systematic review. J Alzheimers Dis 2017; 57(1): 29-36.
[http://dx.doi.org/10.3233/JAD-161250] [PMID: 28222533]
[26]
Danna SM, Graham E, Burns RJ, Deschênes SS, Schmitz N. Association between depressive symptoms and cognitive function in persons with diabetes mellitus: A systematic review. PLoS One 2016; 11(8)e0160809
[http://dx.doi.org/10.1371/journal.pone.0160809]
[27]
McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379(9833): 2291-9.
[http://dx.doi.org/10.1016/S0140-6736(12)60360-2] [PMID: 22683129]
[28]
Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 2004; 328(7439): 548.
[http://dx.doi.org/10.1136/bmj.37977.495729.EE] [PMID: 14980984]
[29]
Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16(2): 93-112.
[http://dx.doi.org/10.1046/j.1464-5491.1999.00027.x] [PMID: 10229302]
[30]
Broadley MM, White MJ, Andrew B. A systematic review and meta-analysis of executive function performance in type 1 diabetes mellitus. Psychosom Med 2017; 79(6): 684-96.
[http://dx.doi.org/10.1097/PSY.0000000000000460] [PMID: 28207612]
[31]
Domenech-Cebrián P, Cauli O. Analysis of functional and cognitive impairment in institutionalized individuals with movement disorders. Endocr Metab Immune Disord Drug Targets 2019; 19(7): 1022-31.
[http://dx.doi.org/10.2174/1871530319666190311104247] [PMID: 30854981]
[32]
Sadanand S, Balachandar R, Bharath S. Memory and executive functions in persons with type 2 diabetes: A meta-analysis. Diabetes Metab Res Rev 2016; 32(2): 132-42.
[http://dx.doi.org/10.1002/dmrr.2664] [PMID: 25963303]
[33]
Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61(5): 661-6.
[http://dx.doi.org/10.1001/archneur.61.5.661] [PMID: 15148141]
[34]
Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract 2017; 124: 41-7.
[http://dx.doi.org/10.1016/j.diabres.2016.10.024] [PMID: 28088029]
[35]
Mule NK, Singh JN. Diabetes Mellitus to Neurodegenerative Disorders: Is oxidative stress fueling the flame? CNS Neurol Disord Drug Targets 2018; 17(9): 644-53.
[http://dx.doi.org/10.2174/1871527317666180809092359] [PMID: 30091419]
[36]
Domenech-Cebrían P, Martinez-Martinez M, Cauli O. Relationship between mobility and cognitive impairment in patients with Alzheimer’s disease. Clin Neurol Neurosurg 2019; 179: 23-9.
[http://dx.doi.org/10.1016/j.clineuro.2019.02.015] [PMID: 30798193]
[37]
Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology 2004; 63(7): 1181-6.
[38]
Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: Evidence from a longitudinal study. Age Ageing 2004; 33(4): 355-61.
[http://dx.doi.org/10.1093/ageing/afh100] [PMID: 15136287]
[39]
Natovich R, Kushnir T, Harman-Boehm I, et al. Cognitive dysfunction: Part and parcel of the diabetic foot. Diabetes Care 2016; 39(7): 1202-7.
[http://dx.doi.org/10.2337/dc15-2838] [PMID: 27208339]
[40]
Tuttolomondo A, Casuccio A, Guercio G, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol 2017; 16(1): 2.
[http://dx.doi.org/10.1186/s12933-016-0483-5] [PMID: 28056981]
[41]
Marseglia A, Xu W, Rizzuto D, et al. Cognitive functioning among patients with diabetic foot. J Diabetes Complications 2014; 28(6): 863-8.
[http://dx.doi.org/10.1016/j.jdiacomp.2014.07.005] [PMID: 25127250]
[42]
Willrich A, Pinzur M, McNeil M, Juknelis D, Lavery L. Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study. Foot Ankle Int 2005; 26(2): 128-34.
[http://dx.doi.org/10.1177/107110070502600203] [PMID: 15737254]
[43]
Kloos C, Hagen F, Lindloh C, et al. Cognitive function is not associated with recurrent foot ulcers in patients with diabetes and neuropathy. Diabetes Care 2009; 32(5): 894-6.
[http://dx.doi.org/10.2337/dc08-0490] [PMID: 19244093]
[44]
Williams RM, Turner AP, Green M, et al. Relationship between cognition and functional outcomes after dysvascular lower extremity amputation: A prospective study. Am J Phys Med Rehabil 2015; 94(9): 707-17.
[http://dx.doi.org/10.1097/PHM.0000000000000235] [PMID: 25357146]
[45]
Lin EHB, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care 2010; 33(2): 264-9.
[http://dx.doi.org/10.2337/dc09-1068] [PMID: 19933989]
[46]
Chapman Z, Shuttleworth CMJ, Huber JW. High levels of anxiety and depression in diabetic patients with charcot foot. J Foot Ankle Res 2014; 7(1): 22.
[http://dx.doi.org/10.1186/1757-1146-7-22] [PMID: 24650435]
[47]
Gonzalez JS, Vileikyte L, Ulbrecht JS, et al. Depression predicts first but not recurrent diabetic foot ulcers. Diabetologia 2010; 53(10): 2241-8.
[http://dx.doi.org/10.1007/s00125-010-1821-x] [PMID: 20556354]
[48]
Fejfarová V, Jirkovská A, Dragomirecká E, et al. Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus? J Diabetes Res 2014; 2014371938
[http://dx.doi.org/10.1155/2014/371938] [PMID: 24791012]
[49]
Simson U, Nawarotzky U, Friese G, et al. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabet Med 2008; 25(2): 206-12.
[http://dx.doi.org/10.1111/j.1464-5491.2007.02370.x] [PMID: 18290863]
[50]
Williams LH, Rutter CM, Katon WJ, et al. Depression and incident diabetic foot ulcers: A prospective cohort study. Am J Med 2010; 123(8): 748-754.e3.
[http://dx.doi.org/10.1016/j.amjmed.2010.01.023] [PMID: 20670730]
[51]
Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer: The role of depression on mortality. Diabetes Care 2007; 30(6): 1473-9.
[http://dx.doi.org/10.2337/dc06-2313] [PMID: 17363754]
[52]
Ahmad A, Abujbara M, Jaddou H, Younes NA, Ajlouni K. Anxiety and depression among adult patients with diabetic foot: Prevalence and associated factors. J Clin Med Res 2018; 10(5): 411-8.
[http://dx.doi.org/10.14740/jocmr3352w] [PMID: 29581804]
[53]
Iversen MM, Tell GS, Espehaug B, et al. Is depression a risk factor for diabetic foot ulcers? 11-years follow-up of the Nord-Trøndelag Health Study (HUNT). J Diabetes Complications 2015; 29(1): 20-5.
[http://dx.doi.org/10.1016/j.jdiacomp.2014.09.006] [PMID: 25283486]
[54]
Coelho CR, Zantut-Wittmann DE, Parisi MCR. A cross-sectional study of depression and self-care in patients with type 2 diabetes with and without foot ulcers. Ostomy Wound Manage 2014; 60(2): 46-51.
[PMID: 24515984]
[55]
Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90.
[http://dx.doi.org/10.1186/1741-7015-9-90] [PMID: 21791035]
[56]
Monami M, Longo R, Desideri CM, Masotti G, Marchionni N, Mannucci E. The diabetic person beyond a foot ulcer: Healing, recurrence, and depressive symptoms. J Am Podiatr Med Assoc 2008; 98(2): 130-6.
[http://dx.doi.org/10.7547/0980130] [PMID: 18347122]
[57]
Vileikyte L, Gonzalez JS, Leventhal H, et al. Patient interpretation of neuropathy (PIN) questionnaire: An instrument for assessment of cognitive and emotional factors associated with foot self-care. Diabetes Care 2006; 29(12): 2617-24.
[http://dx.doi.org/10.2337/dc06-1550] [PMID: 17130194]
[58]
Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 2008; 69(Suppl E1): 4-7.
[PMID: 18494537]
[59]
Cunha MC, Zanetti ML, Hass VJ. Sleep quality in type 2 diabetics. Rev Lat Am Enfermagem 2008; 16(5): 850-5.
[http://dx.doi.org/10.1590/S0104-11692008000500009] [PMID: 19061021]
[60]
Salomé GM, Blanes L, Ferreira LM. Assessment of depressive symptoms in people with diabetes mellitus and foot ulcers. Rev Col Bras Cir 2011; 38(5): 327-33.
[PMID: 22124644]
[61]
Ribu L, Wahl A. Living with diabetic foot ulcers: A life of fear, restrictions, and pain. Ostomy Wound Manage 2004; 50(2): 57-67.
[PMID: 15129612]
[62]
Tennant J, McClelland M, Miller J. Identifying nocturia as a contributor to diabetic foot ulcer healing delays 2015 18(4): 4.
[63]
Wilson RC. The use of low-dose trazodone in the treatment of painful diabetic neuropathy. J Am Podiatr Med Assoc 1999; 89(9): 468-71.
[http://dx.doi.org/10.7547/87507315-89-9-468] [PMID: 10507215]
[64]
Maltese G, Fountoulakis N, Drakatos P, et al. Elevated obstructive sleep apnoea risk score is associated with poor healing of diabetic foot ulcers: A prospective cohort study Diabet Med A J Br Diabet Assoc 2018; 35(11): 1494-98.
[http://dx.doi.org/10.1111/dme.13780]
[65]
Gomes AA, Ackermann M, Ferreira JP, Orselli MIV, Sacco ICN. Muscle force distribution of the lower limbs during walking in diabetic individuals with and without polyneuropathy. J Neuroeng Rehabil 2017; 14(1): 111.
[http://dx.doi.org/10.1186/s12984-017-0327-x] [PMID: 29121964]
[66]
Handsaker JC, Brown SJ, Bowling FL, Marple-Horvat DE, Boulton AJM, Reeves ND. People with diabetic peripheral neuropathy display a decreased stepping accuracy during walking: Potential implications for risk of tripping. Diabet Med 2016; 33(5): 644-9.
[http://dx.doi.org/10.1111/dme.12851] [PMID: 26172114]
[67]
Lamola G, Venturi M, Martelli D, et al. Quantitative assessment of early biomechanical modifications in diabetic foot patients: The role of foot kinematics and step width. J Neuroeng Rehabil 2015; 12: 98.
[http://dx.doi.org/10.1186/s12984-015-0093-6] [PMID: 26553039]
[68]
Nardone A, Corna S, Turcato AM, Schieppati M. Afferent control of walking: Are there distinct deficits associated to loss of fibres of different diameter? Clin Neurophysiol 2014; 125(2): 327-35.
[http://dx.doi.org/10.1016/j.clinph.2013.07.007] [PMID: 23948160]
[69]
Richardson JK, Allet L, Kim H, Ashton-Miller JA. Fibular motor nerve conduction studies and ankle sensorimotor capacities. Muscle Nerve 2013; 47(4): 497-503.
[http://dx.doi.org/10.1002/mus.23618] [PMID: 23225524]
[70]
Zhou H, Al-Ali F, Rahemi H, et al. Hemodialysis impact on motor function beyond aging and diabetes-objectively assessing gait and balance by wearable technology. Sensors (Basel) 2018; 18(11)E3939
[http://dx.doi.org/10.3390/s18113939] [PMID: 30441843]
[71]
Fernando ME, Crowther RG, Lazzarini PA, Sangla KS, Buttner P, Golledge J. Gait parameters of people with diabetes-related neuropathic plantar foot ulcers. Clin Biomech (Bristol, Avon) 2016; 37: 98-107.
[http://dx.doi.org/10.1016/j.clinbiomech.2016.06.006] [PMID: 27389946]
[72]
Labovitz JM, Yu J, Kim C. The role of hamstring tightness in plantar fasciitis. Foot Ankle Spec 2011; 4(3): 141-4.
[http://dx.doi.org/10.1177/1938640010397341] [PMID: 21368068]
[73]
Rao S, Saltzman CL, Yack HJ. Relationships between segmental foot mobility and plantar loading in individuals with and without diabetes and neuropathy. Gait Posture 2010; 31(2): 251-5.
[http://dx.doi.org/10.1016/j.gaitpost.2009.10.016] [PMID: 19926283]
[74]
Francia P, Gulisano M, Anichini R, Seghieri G. Diabetic foot and exercise therapy: Step by step the role of rigid posture and biomechanics treatment. Curr Diabetes Rev 2014; 10(2): 86-99.
[http://dx.doi.org/10.2174/1573399810666140507112536] [PMID: 24807636]
[75]
Azpiroz F, Malagelada C. Diabetic neuropathy in the gut: Pathogenesis and diagnosis. Diabetologia 2016; 59(3): 404-8.
[http://dx.doi.org/10.1007/s00125-015-3831-1] [PMID: 26643877]
[76]
Khalaf K, Al-Angari HM, Khandoker AH, et al. Gait alterations in the UAE population with and without diabetic complications using both traditional and entropy measures. Gait Posture 2017; 58: 72-7.
[http://dx.doi.org/10.1016/j.gaitpost.2017.07.109] [PMID: 28756345]
[77]
Najafi B, Talal TK, Grewal GS, Menzies R, Armstrong DG, Lavery LA. Using plantar electrical stimulation to improve postural balance and plantar sensation among patients with diabetic peripheral neuropathy: A randomized double blinded study. J Diabetes Sci Technol 2017; 11(4): 693-701.
[http://dx.doi.org/10.1177/1932296817695338] [PMID: 28627217]
[78]
Halawa MR, Eid YM, El-Hilaly RA, Abdelsalam MM, Amer AH. Relationship of planter pressure and glycemic control in type 2 diabetic patients with and without neuropathy. Diabetes Metab Syndr 2018; 12(2): 99-104.
[http://dx.doi.org/10.1016/j.dsx.2017.09.010] [PMID: 28964719]
[79]
Scarton A, Jonkers I, Guiotto A, et al. Comparison of lower limb muscle strength between diabetic neuropathic and healthy subjects using OpenSim. Gait Posture 2017; 58: 194-200.
[http://dx.doi.org/10.1016/j.gaitpost.2017.07.117] [PMID: 28802220]
[80]
Richard J-L, Sotto A, Lavigne JP. New insights in diabetic foot infection. World J Diabetes 2011; 2(2): 24-32.
[http://dx.doi.org/10.4239/wjd.v2.i2.24] [PMID: 21537457]
[81]
Spanos K, Saleptsis V, Athanasoulas A, et al. Factors associated with ulcer healing and quality of life in patients with diabetic foot ulcer. Angiology 2017; 68(3): 242-50.
[http://dx.doi.org/10.1177/0003319716651166] [PMID: 27225697]
[82]
Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: State-of-the-art. Diabetes Obes Metab 2014; 16(4): 305-16.
[http://dx.doi.org/10.1111/dom.12190] [PMID: 23911085]
[83]
Elewski BE. Onychomycosis. Treatment, quality of life, and economic issues. Am J Clin Dermatol 2000; 1(1): 19-26.
[http://dx.doi.org/10.2165/00128071-200001010-00002] [PMID: 11702301]
[84]
Armstrong DG. An overview of foot infections in diabetes. Diabetes Technol Ther 2011; 13(9): 951-7.
[http://dx.doi.org/10.1089/dia.2011.0007] [PMID: 21631279]
[85]
Chow I, Lemos EV, Einarson TR. Management and prevention of diabetic foot ulcers and infections: A health economic review. Pharmacoeconomics 2008; 26(12): 1019-35.
[http://dx.doi.org/10.2165/0019053-200826120-00005] [PMID: 19014203]
[86]
Jansen JP, Kumar R, Carmeli Y. Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. Pharmacoeconomics 2009; 27(12): 1045-56.
[http://dx.doi.org/10.2165/11310080-000000000-00000] [PMID: 19908928]
[87]
Martins IJ. Bacterial lipopolysaccharides and neuron toxicity in neurodegenerative diseases. Neurol Neurosurg 2018; 1: 1-3.
[http://dx.doi.org/10.33425/2641-4333.1001]
[88]
Annamanedi M, Kalle AM. Celecoxib sensitizes Staphylococcus aureus to antibiotics in macrophages by modulating SIRT1. PLoS One 2014; 6(9)e99285
[http://dx.doi.org/10.1371/journal.pone.0099285]
[89]
Wellman AS, Metukuri MR, Kazgan N, et al. Intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota. Gastroenterology 2017; 153(3): 772-86.
[http://dx.doi.org/10.1053/j.gastro.2017.05.022] [PMID: 28552621]
[90]
Martins I. Antibiotic use and nuclear receptor inactivation linked to mitophagy in diabetes and chronic diseases. J Diabetes Clin Stud 2018; 2(1)
[91]
Li L, Chen Z, Fu W, Cai S, Zeng Z. Emerging evidence concerning the role of sirtuins in sepsis. Crit Care Res Pract 2018; 85489571
[http://dx.doi.org/10.1155/2018/5489571]
[92]
Liu X, Yang T, Sun T, Shao K. SIRT1-mediated regulation of oxidative stress induced by Pseudomonas aeruginosa lipopolysaccharides in human alveolar epithelial cells. Mol Med Rep 2017; 15(2): 813-8.
[http://dx.doi.org/10.3892/mmr.2016.6045] [PMID: 28000862]
[93]
Zhan X, Stamova B, Sharp FR. Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer’s disease brain: A Review Front Aging Neurosci 2018; 22: 10:42.
[94]
Cenit MC, Sanz Y, Codoñer-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol 2017; 23(30): 5486.
[http://dx.doi.org/10.3748/wjg.v23.i30.5486]
[95]
Lu M, Varley AW, Ohta S, Hardwick J, Munford RS. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe 2008; 4(3): 293-302.
[http://dx.doi.org/10.1016/j.chom.2008.06.009]
[96]
Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 2019; 9(1): 5790.
[http://dx.doi.org/10.1038/s41598-019-42286-8]
[97]
Martins IJ. Antibiotic resistance involves antimicrobial inactivation in global communities. SAJ Pharma Pharmacol 2017; 2: 102.
[98]
Boyanova L, Mitov I. Antibiotic resistance rates in causative agents of infections in diabetic patients: Rising concerns. Expert Rev Anti Infect Ther 2013; 10(11): 411-20.
[http://dx.doi.org/10.1586/eri.13.19]
[99]
Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med 2013; 5(192)192ra85
[http://dx.doi.org/10.1126/scitranslmed.3006055]
[100]
Stefano GB, Samuel J, Kream RM. Antibiotics may trigger mitochondrial dysfunction inducing psychiatric disorders. Med Sci Monit 2017; 23(23): 101-6.
[http://dx.doi.org/10.12659/MSM.899478] [PMID: 28063266]
[101]
Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: The links with dementia development. Protein Cell 2017; 8(2): 90-102.
[http://dx.doi.org/10.1007/s13238-016-0338-6]
[102]
Sternbach H, State R. Antibiotics: Neuropsychiatric effects and psychotropic interactions. Harv Rev Psychiatry 1997; 5(4): 214-26.
[http://dx.doi.org/10.3109/10673229709000304] [PMID: 9427014]
[103]
Zareifopoulos N, Panayiotakopoulos G. Neuropsychiatric effects of antimicrobial agents. Clin Drug Investig 2017; 37(5): 423-37.
[http://dx.doi.org/10.1007/s40261-017-0498-z] [PMID: 28197902]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 8
Year: 2019
Page: [598 - 608]
Pages: 11
DOI: 10.2174/1871527318666191002094406
Price: $65

Article Metrics

PDF: 31
HTML: 4